[go: up one dir, main page]

BR0303373A - Inibidores de hiv protease de sulfonamidas benzimidazol- substituìdas de espectro amplo - Google Patents

Inibidores de hiv protease de sulfonamidas benzimidazol- substituìdas de espectro amplo

Info

Publication number
BR0303373A
BR0303373A BR0303373-2A BR0303373A BR0303373A BR 0303373 A BR0303373 A BR 0303373A BR 0303373 A BR0303373 A BR 0303373A BR 0303373 A BR0303373 A BR 0303373A
Authority
BR
Brazil
Prior art keywords
alkyl
het
alkanediyl
amino
optionally substituted
Prior art date
Application number
BR0303373-2A
Other languages
English (en)
Inventor
Dominique Louis Nest Surleraux
Piet Tom Bert Paul Wigerinck
Marieke Christiane Johan Voets
Sandrine Marie Hele Vendeville
Herman Augustinus De Kock
Bernhard Joanna Bern Vergouwen
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of BR0303373A publication Critical patent/BR0303373A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C07D235/32—Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

"INIBIDORES DE HIV PROTEASE DE SULFONAMIDAS BENZIMIDAZOL-SUBSTITUìDAS DE ESPECTRO AMPLO". A presente invenção refere-se aos compostos tendo a fórmula (I), em que N-óxidos, sais, formas estereoisoméricas, misturas racêmicas, pró-drogas, ésteres e metabólitos destes, em que R~ 1~ e R~ 8~ cada um é H, C~ 1-6~alquila opcionalmente substituída, C~ 2-6~alquenila, C~ 3-7~cicloalquila, arila, Het^ 1^, Het^ 2^; R~ 1~ também pode ser um radical da fórmula (R~ 11a~R~ 11b~)NC(R~ 10a~R~ 10b~)CR~ 9~-; t é 0, 1 ou 2; R~ 2~ é H OU C~ 1-6~alquila; L é -C(=O)-, -O-C(=O)-, -NR~ 8~-C(=O)-, -O-C~ 1-6~alcanodiil-C(=O)-, -NR~ 8~-C~ 1-6~alcanodiil-C(=O)-, -S(=O)~ 2~-, -O-S(=0)~ 2~-, -NR~ 8~-S(=O)~ 2~; R~ 3~ é C~ 1-6~alquila, arila, C~ 3-7~cicloalquila, C~ 3-7~cicloalquilC~ 1-4~alquila ou arilC~ 1-4~alquila; R~ 4~ é H, C~ 1-4~alquilOC(=O), carboxila, aminoC(=O), mono ou di(C~ 1-4~alquil)aminoC(=O), C~ 3-7~cicloalquila, C~ 2-6~alquenila, C~ 2-6~alquinila ou C~ 1-6~ alquila opcionalmente substituída; A é C~ 1-6~alcanodiila, -C(=O)-, -C(=S)-, -S(=O)~ 2~-, C~ 1-6~alcanodiil-C(=O)-, C~ 1-6~alcanodiil-C(=S)- ou C~ 1-6~alcanodiil-S(=O)~ 2~-; R~ 5~ é H, OH, C~ 1-6~alquila, Het^ 1^C~ 1-6~alquila, Het^ 2^C~ 1-6~alquila, amino-C~ 1-6~ alquila opcionalmente substituída; R~ 6~ é C~ 1-6~alquilO, Het^ 1^, Het^ 1^O, Het^ 2^, Het^ 2^O, arila, arilO, C~ 1-6~alquiloxicarbonilamino ou amino; e no caso de -A- ser diferente de C~ 1-6~alcanodiila, então R~ 6~ também pode ser C~ 1-6~alquila, Het^ 1^C~ 1-4~ alquila, Het^ 1^OC~ 1-4~alquila, Het~ 2~C~ 1-4~alquila, Het^ 2^OC~ 1-4~alquila, arilC~ 1-4~alquila, arilOC~ 1-4~ alquila ou aminoC~ 1-4~alquila; onde cada um dos grupos amino na definição de R~ 6~ pode ser opcionalmente substituído; R~ 5~ e -A-R~ 6~ considerados juntos com o átomo de nitrogênio ao qual eles estão ligados podem também formar Het^ 1^ ou Het^ 2^; R^ 12^ é H, -NH~ 2~, -NR~ 5~AR~ 6~, -C~ 1-6~alquila ou alquil-W-R~ 14~, em que a dita alquila é opcionalmente substituída por halogênio, hidróxi, arila, heteroarila, Het^ 1^, Het^ 2^, ou amino em que o dito amino é opcionalmente mono ou dissubstituído por C~ 1-4~alquila e R~ 13~ é H, C~ 1-6~-alquila opcionalmente substituída por arila, Het^ 1^, Het^ 2^, hidróxi, halogênio, amino onde o grupo amino pode ser opcionalmente mono ou dissubstituído por C~ 1-4~alquila.
BR0303373-2A 2002-03-12 2003-03-12 Inibidores de hiv protease de sulfonamidas benzimidazol- substituìdas de espectro amplo BR0303373A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02075999 2002-03-12
PCT/EP2003/050057 WO2003076413A1 (en) 2002-03-12 2003-03-12 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors

Publications (1)

Publication Number Publication Date
BR0303373A true BR0303373A (pt) 2004-03-23

Family

ID=27798870

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0303373-2A BR0303373A (pt) 2002-03-12 2003-03-12 Inibidores de hiv protease de sulfonamidas benzimidazol- substituìdas de espectro amplo

Country Status (25)

Country Link
US (2) US20050171175A1 (pt)
EP (1) EP1485358B1 (pt)
JP (1) JP4557552B2 (pt)
KR (3) KR20120136411A (pt)
CN (2) CN1653053A (pt)
AP (1) AP2111A (pt)
AR (1) AR038928A1 (pt)
AT (1) ATE497494T1 (pt)
AU (1) AU2003219159B2 (pt)
BR (1) BR0303373A (pt)
CA (1) CA2479012C (pt)
DE (1) DE60335939D1 (pt)
DK (1) DK1485358T3 (pt)
EA (1) EA011946B1 (pt)
HR (1) HRP20040936B1 (pt)
IL (1) IL163960A0 (pt)
MX (1) MXPA04008929A (pt)
MY (1) MY142238A (pt)
NO (1) NO326702B1 (pt)
NZ (1) NZ535439A (pt)
PL (1) PL213645B1 (pt)
SI (1) SI1485358T1 (pt)
TW (1) TWI329639B (pt)
WO (1) WO2003076413A1 (pt)
ZA (1) ZA200407242B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070123574A1 (en) * 2003-09-30 2007-05-31 De Kock Herman A Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof
AU2005244121B2 (en) * 2004-05-07 2012-01-19 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
DK1856125T3 (da) 2005-02-25 2009-12-07 Tibotec Pharm Ltd Syntese af proteasehæmmerforstadie
UA103013C2 (uk) * 2007-12-06 2013-09-10 Тиботек Фармасьютикелз Амідні сполуки як активатори противірусних препаратів
WO2011061590A1 (en) 2009-11-17 2011-05-26 Hetero Research Foundation Novel carboxamide derivatives as hiv inhibitors
WO2013011485A1 (en) * 2011-07-20 2013-01-24 Ranbaxy Laboratories Limited Process for the preparation of sulfonamides useful as retroviral protease inhibitors

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
JP3657002B2 (ja) * 1992-08-25 2005-06-08 ジー．ディー．サール アンド カンパニー レトロウイルスプロテアーゼ阻害剤として有用なα−およびβ−アミノ酸ヒドロキシエチルアミノスルホンアミド
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
DK0715618T3 (da) 1993-08-24 1999-08-23 Searle & Co Hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser
CN1110300C (zh) 1993-10-01 2003-06-04 阿斯特拉公司 工艺技术ⅰ
EP0804428B1 (en) * 1995-01-20 2007-12-26 G.D. Searle LLC. Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
US5756533A (en) * 1995-03-10 1998-05-26 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6140505A (en) * 1995-03-10 2000-10-31 G. D. Searle & Co. Synthesis of benzo fused heterocyclic sulfonyl chlorides
US5776971A (en) * 1995-03-10 1998-07-07 G.D. Searle & Co. Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US5705500A (en) * 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US6150556A (en) * 1995-03-10 2000-11-21 G. D. Dearle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
WO1996028465A1 (en) * 1995-03-10 1996-09-19 G.D. Searle & Co. Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
AU7722296A (en) 1995-11-15 1997-06-05 G.D. Searle & Co. Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
ATE255883T1 (de) 1996-05-20 2003-12-15 Janssen Pharmaceutica Nv Fungizide mittel mit verbesserter bioverfügbarkeit
AP1227A (en) 1997-03-26 2003-11-24 Janssen Pharmaceutica Nv Pellets having a core coated with an antifungal and a polymer.
WO1999006587A2 (en) * 1997-08-01 1999-02-11 Morphosys Ag Novel method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex
AU2012199A (en) 1997-12-24 1999-07-19 Vertex Pharmaceuticals Incorporated Prodrugs of aspartyl protease inhibitors
WO1999033792A2 (en) 1997-12-24 1999-07-08 Vertex Pharmaceuticals Incorporated Prodrugs os aspartyl protease inhibitors
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
AP2000001856A0 (en) 1997-12-24 2000-09-30 Vertex Pharma Prodrugs of aspartyl protease inhibitors.
CA2335477C (en) * 1998-06-19 2010-11-30 Vertex Pharmaceuticals Incorporated Sulfonamide inhibitors of aspartyl protease
WO1999067254A2 (en) * 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Multi-drug resistant retroviral protease inhibitors and use thereof
AR031520A1 (es) * 1999-06-11 2003-09-24 Vertex Pharma Un compuesto inhibidor de aspartilo proteasa, una composicion que lo comprende y un metodo para tratar un paciente con dicha composicion

Also Published As

Publication number Publication date
AU2003219159B2 (en) 2009-09-03
US20050171175A1 (en) 2005-08-04
SI1485358T1 (sl) 2011-05-31
CA2479012C (en) 2011-11-01
EP1485358A1 (en) 2004-12-15
US8143421B2 (en) 2012-03-27
AP2004003151A0 (en) 2004-12-31
ZA200407242B (en) 2005-12-28
AP2111A (en) 2010-03-03
IL163960A0 (en) 2005-12-18
KR20040093119A (ko) 2004-11-04
CN101935303A (zh) 2011-01-05
CA2479012A1 (en) 2003-09-18
EA011946B1 (ru) 2009-06-30
CN101935303B (zh) 2014-03-12
EA200401188A1 (ru) 2005-04-28
PL213645B1 (pl) 2013-04-30
WO2003076413A1 (en) 2003-09-18
MXPA04008929A (es) 2004-11-26
NZ535439A (en) 2009-09-25
ATE497494T1 (de) 2011-02-15
KR20120136411A (ko) 2012-12-18
KR101302421B1 (ko) 2013-09-02
NO20035023D0 (no) 2003-11-12
NO326702B1 (no) 2009-02-02
KR20100102742A (ko) 2010-09-24
AR038928A1 (es) 2005-02-02
DK1485358T3 (da) 2011-05-09
MY142238A (en) 2010-11-15
HRP20040936B1 (hr) 2012-09-30
TW200400945A (en) 2004-01-16
TWI329639B (en) 2010-09-01
HRP20040936A2 (en) 2005-10-31
DE60335939D1 (de) 2011-03-17
HK1072053A1 (en) 2005-08-12
EP1485358B1 (en) 2011-02-02
JP4557552B2 (ja) 2010-10-06
CN1653053A (zh) 2005-08-10
AU2003219159A1 (en) 2003-09-22
PL374152A1 (en) 2005-10-03
US20090203743A1 (en) 2009-08-13
JP2005519952A (ja) 2005-07-07

Similar Documents

Publication Publication Date Title
BR0207862A (pt) Inibidores de protease de hiv 2-(amino-substituìda)-benzotiazol-sulfonamida de amplo espectro
AR046118A1 (es) Procedimiento para la preparacion de compuestos de aminocrotonilo
BR0303373A (pt) Inibidores de hiv protease de sulfonamidas benzimidazol- substituìdas de espectro amplo
UY39296A (es) Azaquinolonas sustituidas inhibidoras de parp y composiciones farmacéuticas que las contienen
UY28671A1 (es) Pirido(2.3-d)pirimidina-2,4-diaminas como inhibidores de pde 2
AR064493A1 (es) Derivados de isoquinolina e isoquinolinona sustituidos
UY31193A1 (es) Derivados de 6-cicloamino-3-(piridin-4-il)imidazo[1,2-b]-piridazina, su preparasción y su aplicación en terapéutica
BR112013029711A2 (pt) compostos
ATE516026T1 (de) Bicyclisches carbamoylpyridonderivat mit hiv- integrase-hemmender wirkung
BRPI0413861A (pt) compostos de pirimidotiofeno
AR042438A1 (es) Derivados de fluorglicosidos aromaticos, medicamentos que contienen estos compuestos y sus usos
BRPI0606480A (pt) compostos farmacêuticos
AR064533A1 (es) Derivados de isoquinolina e isoquinolinona sustituidos y su uso en la produccion de un medicamento para el tratamiento de enfermedades relacionadas con la inhibicion de la rho-quinasa.
BR112017009601A2 (pt) derivados de aminoácidos e seus usos
BRPI0511768A (pt) composto, pró-droga, métodos para a produção de um composto, e para a profilaxia ou tratamento de cáncer em um mamìfero, agente farmacêutico, e, uso de um composto
MA32405B1 (fr) SELS DE 2-FLUORO-N-MÉTHYL-4-[7-(QUINOLÉIN-6-YL-MÉTHYL)- IMIDAZO[1,2-B][1,2,4]TRIAZIN-2-YL]BENZAMIDE ET PROCÉDÉS ASSOCIÉS à LEUR PRÉPARATION
CR10778A (es) Derivados de sulfonil-fenil-2h-[1,2,4]oxadiaxol-5-ona, procedimientos para su preparacion y su uso como agentes farmaceuticos
UY27761A1 (es) Derivados de acil-4-carboxifenilurea, procedimientos para su preparcción y su uso.
NI200800021A (es) Derivados de n - (arilalquil) - 1h - pirrolopiridin - 2 - carboxamidas, su preparación y su aplicación en terapéutica
BR112021018692A2 (pt) 1,1-dióxido de isotiazolidina e 1,4-butanossultona contendo derivados de rapamicina e usos dos mesmos
AR035196A1 (es) Derivados de guanidina o biguanidina y el uso de los mismos para la fabricacion de medicamentos antivirales y antimicrobianos
BRPI0519979A2 (pt) composto ou estereoisÈmeros, misturas de estereoisÈmeros ou sais farmaceuticamente aceitáveis dos mesmos, composição farmacêutica, e, uso de um composto
CO6320143A1 (es) Nuevos derivados dihidroindolonas su procedimeinto de preparacion y composiciones farmaceuticas que los contienen
BR0305771A (pt) Inibidores de protease do hiv oxindol sulfonamida substituìdos de amplo espectro
UY29690A1 (es) Derivados de n-(heteroaril)-1-heteroarilalquil-1h-indol-2-carboxamidas, su preparación y su aplicación en terapéutica.

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: TIBOTEC PHARMACEUTICALS LTD. (IE)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020070001806/RJ DE 05/01/2007.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 14A ANUIDADE.

B07F Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]